Uncategorized
Research and Markets: United States Bacterial Conjunctivitis Drugs Market Study 2015 – Fluoroquinolones to be the Largest Segment by 2024
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6vkbvx/the_u_s_market) has announced the addition of the "The U.S Market Study on Bacterial Conjunctivitis Drugs: Fluoroquinolones to be the Largest Segment by 2024" report to their offering. The cost of treating bacterial conjunctivitis ranges from USD 377 million to USD 857 million annually in the U.S. It also quoted that majority of conjunctivitis patients are originally treated by primary care physicia
